Endine

Quick links to important sections

Endine

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Endine

Endone Quick Facts

This table summarizes the core identity of the medicine for quick reference.

Property Description
Active Ingredient Oxycodone Hydrochloride
Form Immediate-Release Oral Tablet (e.g., 5 mg)
Pharmacological Class Opioid/Narcotic Analgesic
General Purpose Management of severe short-term pain
Origin Semi-Synthetic Compound

Endone: A Targeted Pain Medicine

Endone is a brand name for the active medicine oxycodone hydrochloride, classified as a narcotic analgesic (or opioid) used in the medical management of severe pain. It is a semi-synthetic compound, derived from the opium alkaloid thebaine, and its primary function is to interrupt the transmission of pain signals to the brain.

This medicine is clinically recognized for its potency in treating acute, severe pain that has not been adequately managed by non-opioid options. Unlike extended-release formulations of the same active ingredient, Endone is an immediate-release tablet, designed to provide relief quickly. This particular formulation is commonly used for the short-term management of pain, such as that experienced after a major injury or surgical procedure.


Composition and General Use

Endone tablets contain the active substance oxycodone hydrochloride, which acts directly on the central nervous system. The typical tablet form is designed for oral administration and rapid absorption. The general therapeutic purpose of Endone is to reduce the feeling of severe pain, allowing patients to better manage their recovery or condition.

Oxycodone is used in clinical settings when other, less potent forms of pain relief are insufficient for the severity of the patient's pain. This means the medicine serves as an important option for acute discomfort when necessary. Due to its potent nature, its prescription is highly controlled to ensure appropriate use and management under strict medical supervision.

Regulatory References

  1. Opioids and Opioid Use Disorder (OUD) - MedlinePlus
  2. Oxycodone: MedlinePlus Drug Information

What side effects are possible with Endine?

Possible Side Effects and Safety Information

Endone, containing oxycodone, is associated with a safety profile typical of strong opioid analgesics, carrying several serious risks and common adverse reactions documented in regulatory warnings.


Serious and Clinically Significant Risks

Respiratory Depression is the most significant serious risk, which can be life-threatening or fatal. This risk is highest upon treatment initiation or following a dose increase.

Abuse, Misuse, and Addiction are inherent risks, even at recommended doses, which can lead to overdose and death. Physical dependence can develop, and abrupt discontinuation may result in a severe opioid withdrawal syndrome.

Concomitant use with other central nervous system (CNS) depressants, including alcohol and benzodiazepines, significantly increases the risk of profound sedation, respiratory depression, coma, and death.

Chronic use during pregnancy may result in Neonatal Opioid Withdrawal Syndrome (NOWS) in the newborn. Other serious reactions include Adrenal Insufficiency and severe hypotension.


Common Adverse Reactions

The most commonly reported adverse reactions, based on clinical trial data (incidence >5%), primarily involve the Gastrointestinal and Central Nervous Systems. These frequently include:

  • Gastrointestinal: Constipation, Nausea, Vomiting, Dry Mouth.
  • Nervous System: Somnolence (drowsiness), Dizziness, Headache.
  • Dermatological: Pruritus (itching), Sweating.

Population and Contraindications

Contraindications include significant respiratory depression, acute or severe bronchial asthma in an unmonitored setting, and known or suspected paralytic ileus. Caution is advised for the elderly, patients with pre-existing respiratory issues, and those with hepatic or renal impairment, as these groups may be at an increased risk of severe adverse effects.

Overdose and Emergency Response

Overdose and When to Seek Help

The regulatory documentation for oxycodone hydrochloride (Endone) details specific manifestations of an overdose, which is considered a severe, life-threatening emergency.

Documented Overdose Manifestations

An overdose may present with signs of severe Central Nervous System (CNS) Depression, including profound sedation, somnolence, confusion, or progression to coma. The most critical manifestation is Respiratory Depression, characterized by slow or shallow breathing, which can escalate to apnea (no breathing). Other documented clinical signs include miosis (pinpoint pupils), severe hypotension, and cold, clammy skin. The primary severe outcome cited in official labeling is fatal respiratory depression and circulatory collapse.

When to Seek Immediate Medical Help

The official guidance mandates that immediate medical attention must be sought for any suspected overdose or the onset of severe CNS or respiratory depression. This is considered an emergency. For known overdose, Naloxone is the specific opioid antagonist referenced in regulatory documents for emergency management. Symptomatic and supportive treatment, including necessary ventilatory support, is required.

Specific patient populations carry increased documented risk. Accidental ingestion by a child, even of a single dose, is officially cited as capable of resulting in a fatal overdose. Furthermore, the risk of life-threatening respiratory depression is documented to be increased in the elderly, debilitated patients, and those with chronic pulmonary disease.

Therapeutic Uses of Endine

What Endone Treats: Main Uses and Benefits

The primary role of immediate-release oxycodone (the active ingredient in Endone) is the symptomatic management of moderate-to-severe pain in situations where alternative pain management strategies are inadequate.

This medicine may be applied across domains where additional symptomatic support is needed for symptoms related to physical discomfort, which may also interfere with daily functioning. This supports managing symptom clusters that may become intense or disruptive, which may assist with coping more steadily during difficult symptomatic periods.

It is commonly used across conditions characterized by periods of heightened symptoms, including pain following major surgical procedures, traumatic events, or sudden, disruptive flare-ups known as breakthrough pain. This medicine is relevant in contexts where additional symptomatic support is needed for sudden, more disruptive flare-ups, and assists with necessary recovery activities.

Symptom Focus

Context Benefit
Severe Pain Supports managing symptom clusters that may become intense or disruptive.
Acute Contexts Assists with maintaining functional stability in post-surgical or post-trauma recovery.
Episodic Pain Supports general well-being during symptomatic periods.

Regulatory References

  1. NIH StatPearls on Oxycodone

Eligibility and Restrictions for Use

Who can and cannot use Endone?

The use of immediate-release oxycodone (Endone) is strictly defined by regulatory authorities to ensure patient safety and is established primarily for adult patients with severe pain.


Absolute Contraindications

The medicine is contraindicated for patients with a known hypersensitivity to oxycodone or any excipient, or those experiencing significant respiratory depression. It must not be used in cases of acute or severe bronchial asthma in an unmonitored setting, known or suspected paralytic ileus (gastrointestinal obstruction), or in patients concurrently taking Monoamine Oxidase Inhibitors (MAOIs).


Population and Condition Restrictions

Use in older adults requires caution due to increased sensitivity. The medicine is not recommended during lactation and late pregnancy due to the risk of Neonatal Opioid Withdrawal Syndrome. Conditional use with close monitoring is required for patients with severe renal or hepatic impairment, head injury, increased intracranial pressure, and severe chronic lung diseases like COPD.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Officially documented interaction patterns with oxycodone (Endone's active ingredient) fall into two critical categories: alterations in the body's processing of the medicine and additive effects on the central nervous system (CNS).

Metabolic (Pharmacokinetic) Interactions

Oxycodone is processed primarily by the CYP3A4 enzyme. Substances that act as strong CYP3A4 Inhibitors may increase the medicine's concentration in the blood, potentially prolonging adverse effects. Conversely, CYP3A4 Inducers may decrease the medicine’s plasma concentration, which could lead to reduced effectiveness.

Pharmacodynamic Interactions and Restrictions

The co-administration of CNS Depressants (including benzodiazepines and other opioid medicines) may cause additive effects, leading to profound sedation and respiratory depression. A formal restriction is placed on co-administration with Monoamine Oxidase Inhibitors (MAOIs), a combination that must be avoided, including for 14 days following discontinuation of an MAOI. Furthermore, the co-administration of Serotonergic Drugs is officially noted to carry the potential risk for serotonin syndrome. The use of alcohol is strongly restricted due to the serious, documented risk of intensifying CNS depressant effects, leading to profound sedation and death. Cautions regarding interaction severity are specifically noted for elderly, cachectic, or debilitated patients.

Mechanism of Action

Opioid Receptor Activation in the Central Nervous System

Endone (oxycodone) acts as an agonist by binding to and activating specific mu (mu), kappa (kappa), and delta (delta) opioid receptors, particularly those in the central nervous system. This binding initiates a G-protein coupled signaling cascade inside the neurons.


⬇️ Modulation of Neuronal Excitability

The signaling cascade triggered by Endone binding to opioid receptors results in the inhibition of adenylate cyclase and a decrease in intracellular cAMP. Physiologically, this action leads to the hyperpolarization and reduced excitability of neurons, which dampens signaling within pathways characterized by afferent pathway activity.


Neurotransmitter Release Suppression

This mechanism modifies early molecular steps, specifically by promoting the closure of N-type voltage-gated calcium channels and the opening of potassium channels. This dual effect ultimately inhibits the release of various nociceptive neurotransmitters from the presynaptic terminals, resulting in decreased mediator efflux from presynaptic vesicles and modulating signal propagation within the targeted pathways.

Dosage and Administration Information

Administration Guidelines for Endone

Endone is a brand name for immediate-release oxycodone hydrochloride and is administered exclusively via the oral route, typically as a tablet, capsule, or solution. The medicine can generally be taken with or without food.


Dosing and Scheduling

For an opioid-naïve adult, treatment is initiated in the dose range of 5 mg to 15 mg per single use. The medicine is scheduled to be taken every 4 to 6 hours as needed for acute pain management. For the management of chronic pain, the dose should be administered on a regular, around-the-clock schedule to maintain continuous relief, and the total duration of use should be the shortest time consistent with treatment goals. The appropriate individual dose is achieved through careful titration (adjustment) to find the lowest effective dosage.


Population-Specific Instructions

Dose modifications are recommended for specific populations. For patients with hepatic impairment (liver function issues) or debilitated older adults, it is advised to initiate treatment at one-third to one-half the recommended starting dosage and increase the dose slowly. Similarly, for patients with renal impairment (kidney function issues), a dose reduction, often by 50% of the adult starting dose, is often advised.


Procedural Requirements

If the medicine has been taken regularly over a period, it must not be abruptly discontinued. Instead, the dose should be gradually reduced to prevent rapid discontinuation effects. If a patient misses a scheduled dose, the instruction is to take the next dose at the next regularly scheduled time.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Endone (Oxycodone IR)

Evidence for Use in Acute Postoperative Pain

The available research on immediate-release oxycodone has been conducted in contexts involving acute postoperative pain. Researchers have primarily used short-term Randomized Controlled Trials (RCTs) to explore how symptoms change over time in opioid-naïve adult patients following various surgical procedures. These studies monitored patient-reported outcomes describing perceived discomfort, such as changes in pain intensity scores, and tracked the consumption of supplemental pain relief. Findings describe patterns observed in the change in pain intensity measurements shortly after administration. The evidence describes symptom patterns observed in the immediate recovery phase. However, these studies were largely limited to short follow-up durations, typically observing responses only over the initial few days to a few weeks after surgery.

Evidence for Use in Managing Cancer-Related Breakthrough Pain

Research has also explored the use of the immediate-release formulation in patients managing cancer-related breakthrough pain. Studies relevant in trials assessing episodic symptom patterns include systematic reviews and comparative analyses, often in populations already receiving scheduled pain treatment. Research examined the change in symptom intensity that patients reported shortly after taking the medicine for a pain flare-up. Studies report how symptoms evolved in the observed populations, and findings indicate patterns in the patient-reported frequency of these acute episodes. Certainty in this area remains lower compared to postoperative pain due to the complex nature of the patient populations studied, often involving modest sample sizes and some heterogeneity across studies.

Research on Long-Term Outcomes and Follow-up Duration

The majority of controlled evidence comes from trials where follow-up durations were limited, typically lasting days or a few weeks. This means that long-term outcomes, such as the symptom patterns beyond the short acute phase or the durability of response, are not fully established by the core regulatory studies. Studies examining long-term effects often shift from controlled RCTs to observational or post-marketing settings, which track real-world use but introduce more variables. The available research provides context but not individual predictions about long-term use.

Key Studies & References

  1. Oral Oxycodone for Acute Postoperative Pain: A Review of Clinical Trials
  2. Oxycodone - StatPearls - NCBI Bookshelf (NIH - Clinical and Indication Overview)

Frequently Asked Questions (FAQ)

Common questions about Endone (FAQ)


Q: What is the main difference between Endone and other pain medication in the same class?

Regulatory information indicates that all opioid medicines produce pain-relieving effects through a similar mechanism. The primary differences among them are generally related to their potency (the dose needed to achieve relief) and their duration of action (how long the pain relief is expected to last).


Q: Does Endone treat all types of pain, or only specific kinds?

Official product labeling from regulatory agencies states that Endone (oxycodone) is indicated only for the management of pain that is severe enough to require an opioid analgesic. It is intended for situations where non-opioid pain relief options are insufficient or inadequate to manage the discomfort.


Q: Why is Endone considered a strong pain relief option?

Endone is classified as a potent pain reliever because its active ingredient acts as a full opioid agonist. This means it fully activates specific opioid receptors in the brain and spinal cord, initiating a signal that powerfully blocks the feeling of pain. This mechanism is associated with its classification as a strong analgesic.


Q: How quickly does Endone typically start to work after taking it?

Because Endone is an immediate-release formulation, it is designed to act quickly. Available information indicates that fast-acting oxycodone preparations are associated with pain relief typically starting within about 30 minutes after being taken.


Q: Are there any major diet restrictions when taking Endone?

Official documentation strongly restricts the use of alcohol with this medicine due to the serious risk of increased side effects. Additionally, consuming grapefruit or grapefruit juice may interfere with how the body processes the medicine, potentially increasing its concentration in the blood and raising the risk of adverse effects.


Q: Can Endone interact with common over-the-counter pain relievers like ibuprofen?

Regulatory documents indicate that co-administration with non-opioid, over-the-counter pain relievers such as paracetamol, ibuprofen, or aspirin is typically permitted. However, co-administration with other painkillers containing codeine or similar opioid substances is typically restricted.


Q: Can Endone be used by elderly people?

The use of Endone in elderly patients is not prohibited but must be done with caution and close monitoring. Official warnings indicate that older adults are at an increased risk of severe adverse effects, particularly respiratory depression (slowed breathing), which is why treatment may be initiated at a lower dosage.


Q: Is Endone appropriate for use in children?

Yes, oxycodone, the active ingredient in Endone, is used to treat severe pain in children, such as pain following a surgical operation. Any decision regarding the use or dosage of this medicine in a child should be managed by a qualified healthcare professional.


Q: What risks are associated with long-term use of Endone?

Long-term use is associated with the potential for developing physical dependence and tolerance. Official labeling also warns that chronic opioid use may affect the body’s endocrine system, potentially leading to issues such as androgen deficiency and infertility.


Q: Does Endone cause changes in mood or make people feel confused?

Official information acknowledges that oxycodone may cause side effects in the nervous system, including confusion and mental or mood changes. If a person experiences severe confusion or other unusual changes in thinking or mood, official guidance notes that immediate medical attention may be required.


Q: Does Endone affect a person's ability to drive or operate machinery?

Official warnings state that Endone can significantly impair the mental and physical abilities needed for complex tasks. Official warnings typically caution against driving a car or operating machinery until an individual is aware of the medicine's effects and any initial sedative effects have stabilized.


Q: Do regulatory bodies have a special warning label for Endone?

Yes. Regulatory bodies, such as the FDA, require that oxycodone products carry a Boxed Warning in their official labeling. This warning highlights the highest risks associated with the medicine, including addiction, abuse, misuse, and life-threatening respiratory depression.


Q: Does Endone interact with herbal supplements?

Authoritative sources note that many complementary medicines, herbal remedies, and supplements have not been scientifically tested for drug interactions with Endone. Therefore, there may not be enough information available to confirm their safe co-administration.


Q: Can I take Endone if I have stomach ulcers?

While not an absolute contraindication for all formulations, certain pre-existing conditions like an active history of peptic ulcer disease (stomach ulcers) may require close monitoring. The medicine should be used with caution, as it may increase the risk of serious gastrointestinal side effects.


Q: Is Endone used for chronic pain management?

Endone (immediate-release oxycodone) is primarily indicated for moderate to severe pain on a short-term basis. However, the extended-release form of the same active ingredient is indicated for managing chronic moderate to severe pain that requires continuous, around-the-clock opioid treatment.


Q: Is Endone used for nerve pain?

Regulatory documents state that oxycodone is generally indicated for pain severe enough to require an opioid. While it may be used to treat various types of pain, the official indications do not specifically name neuropathic pain (nerve pain) as a primary target for treatment.


Q: Does Endone affect blood pressure?

Yes, oxycodone can cause vasodilation (widening of blood vessels), which may lead to hypotension (low blood pressure) or fainting. Severe hypotension is listed in official documentation as a serious, though less common, risk associated with the medicine.


Q: Is it known to interact with commonly prescribed antidepressants?

Yes. Official drug labeling warns that using Endone at the same time as serotonergic drugs, which include many commonly prescribed antidepressants, can increase the risk of a serious condition called serotonin syndrome.


Q: What are the signs of a possible serious allergic reaction to Endone?

Signs of a serious allergic reaction include symptoms such as a skin rash, itching, hives, or swelling of the face, lips, tongue, or throat. Official documentation indicates that the occurrence of these signs typically requires immediate medical attention.


Q: Does Endone lose its effectiveness over time (tolerance)?

Studies and official information indicate that a person may develop analgesic tolerance over time. Tolerance means that the dose previously used to achieve pain relief may no longer be as effective, and a higher minimum effective dose may be required to relieve the pain.


Q: Are there any known interactions between Endone and grapefruit juice?

Yes. Official labeling notes that grapefruit juice can interfere with the specific liver enzyme (CYP3A4) responsible for breaking down oxycodone. This interference may increase the concentration of the medicine in the blood, potentially increasing the risk of adverse side effects.


Q: Is there a link between Endone and sleep apnea in official literature?

Breathing or lung conditions such as sleep apnea are often listed as conditions where the medicine should be used with caution. The risk is that Endone, being an opioid, could increase the risk of respiratory depression (slowed breathing) in patients with pre-existing breathing issues.


Q: Is the research evidence for Endone considered strong?

Regulatory bodies have reviewed the evidence for immediate-release oxycodone, concluding that it demonstrates comparable efficacy and safety to other potent opioids for pain management. However, official documents note that the majority of controlled evidence comes from short-term trials.


Q: Are there different forms or strengths of Endone available?

The active ingredient, oxycodone, is available in both immediate-release (IR) tablets like Endone, and extended-release (ER) tablets. Immediate-release products are available in various strengths, with 5 mg being a common starting point.


Q: What is the difference between immediate-release and extended-release forms of the active ingredient?

The difference is in how the medicine is delivered to the body. Immediate-release forms, like Endone, are designed to release the medicine quickly for rapid pain relief. Extended-release forms release the medicine slowly over a longer period to maintain continuous relief.


Q: What are the official guidelines regarding maximum treatment duration with Endone?

Official regulatory documents emphasize that Endone should be used for the shortest duration of time possible. Treatment duration should always be consistent with the individual patient's treatment goals, and its use should not be extended unless the pain remains severe and requires continued opioid management.


Q: Why is Endone a controlled substance?

Endone (oxycodone) is classified as a Schedule II controlled substance by regulatory agencies because it is an opioid agonist that carries a high, inherent risk of addiction, abuse, and misuse. This classification requires strict control over its prescription and dispensing.

How should Endine be stored and disposed of?

How to Store and Dispose of Endone (Oxycodone Hydrochloride)

Official regulatory guidelines strictly define the storage and disposal of Endone tablets to maintain product stability and prevent accidental ingestion.

Storage Requirements

Storage Component Official Requirement
Temperature Store below 30°C (86°F), commonly defined as Controlled Room Temperature.
Environment Keep in a cool, dry place, protected from light and excessive moisture.
Security Must be secured in a locked location and kept out of reach of young children.
Packaging Keep the medicine in the original container and ensure it is tightly closed.

Disposal Instructions

Because oxycodone is a controlled substance, disposal must adhere to specific governmental protocols. The primary method is utilizing an authorized drug take-back program. If a take-back option is not immediately available, the tablets must be flushed down the toilet, as this opioid is listed on the FDA's guidance list due to the high risk of harm from accidental exposure.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Endine found in:

A-Z Index: